Letters Prostate cancer screening

Study has major shortcomings

BMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d3704 (Published 14 June 2011) Cite this as: BMJ 2011;342:d3704
  1. Fritz H Schroder, urologist1
  1. 1Erasmus Medical Centre, Rotterdam, Netherlands
  1. secr.schroder{at}erasmusmc.nl

Although Sandblom and colleagues’ study is the longest follow-up to date of prostate cancer screening,1 it has some major shortcomings.

  • (1) The group of men randomised to screening is small. Of the 1494 men, only 1161 participated in the initial screening (78%). Those who refused are apparently …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe